ContributorsPublishersAdvertisers

Dr. Popat on Investigational Strategies for Belantamab Mafodotin–Related Keratopathy in Multiple Myeloma

onclive.com
 2021-10-25

Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD, discusses investigational strategies to mitigate belantamab mafodotin-blmf–related keratopathy in multiple myeloma. Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD, consultant hematologist, University College Hospital, honorary associate professor, University College London, discusses investigational strategies to mitigate belantamab mafodotin-blmf (Blenrep)–related...

www.onclive.com

Comments / 0

Comments / 0